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In this paper I discuss agricultural biotechnology from an industry perspective,
with reference to products and future trends, describing some of the new
technologies and what they will mean to the farmer and to the industry as a
whole.
In common with other companies, we at Monsanto realize the need to
contribute to the feeding of two billion more people over the next 20 to 30
years, while respecting the environment. To rely on the methods of increasing
food production that were used over the past two to three decades would be
detrimental to the environment and, therefore, not sustainable in the long term.
Moreover, we anticipate that increasing demands for improved food quality will
influence what agricultural products reach the market place.
CHALLENGES
Those are the challenges for agriculture, but what of the challenges for
biotechnology? From an industry perspective, the state of affairs is more
complex and less monopolistic than may be immediately apparent from the
outside. For those who have invested in the area, there are complex issues
related to patenting, for example. It is relatively easy for a small player to
develop a significant patent that is required to deliver a new product to the
market place. But, regulatory systems, which are still evolving worldwide, must
be in place. For example, we were able to introduce new technology into Brazil
only after a regulatory system was instituted there.
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Consumer acceptance varies considerably from one part of the world to
another. Currently, Europe is our biggest challenge and we do not expect
to commercialize biotechnology products, including new crop varieties, there
in the near future.
There is intense competition in getting biotechnology products to the
marketplace, with investment of large sums of money necessary, much of it
from other industries. The closest model, for the foreseeable future, is the
electronics industry — incredibly rapid developments in technology and
capability, with many players involved. I expect increasing competitiveness,
a view not shared by everyone.
CHANGES
During a recent visit to Boston, I asked one of our research laboratory leaders
about changes in productivity, regarding the sequencing of genes of agricultural
crops. Seven years ago, as a graduate student at a university lab, it took him a
year to sequence one gene — extensive work and a great deal of hard labor.
He pointed to one of a long row of instruments and said: “That machine will
sequence 2,500 genes during this 24-hour period.” What took one person a
whole year now can be done 2,500 times over in one day — and that row of
machines is in operation 24 hours a day! It is likely that, for the major crops,
the complete sequences of their 80,000 or more genes will be known within
two years. Clearly, this is a time of great change in the biotechnology industry.
Around the world, government support for crop production is declining, a
trend we expect to continue. Just as with industry, growers are consolidating to
meet increasing demands for food. As biotechnology brings new opportunities,
information is much more available today than it was even five years ago and
growers are commensurately more sophisticated. To achieve higher yields, there
is a significant shift in emphasis from the chemical inputs of the last decades to
crop capability. For example, weed control was formerly limited to herbicide
choices with quite distinct criteria involved in the selection of a seed variety.
Now these decisions are interconnected — by planting soybean containing
the Roundup Ready® gene, the farmer can apply a herbicide that could not
previously be used on that crop. Until recently, the chemical, biotechnology,
and seed industries were distinct, but this is no longer the case and food is just
the next component. Food production, and the ability to improve food quality,
will be dramatically affected by biotechnology.
By 2020, there will be about two billion more mouths to feed, largely as a
result of population growth in the developing world. Over this time frame, the
per capita Gross Domestic Product of the U.S. and Europe are expected to
double, whereas those of China and India, for example, will increase five to six
fold, bringing new financial capabilities. It is likely that improved quality of
food will become a priority in Asia, with shifts in preference from cereal grains
to meat and milk products, creating a total increase in demand for food of 75
percent over that for 1990.
BIOTECHNOLOGY’S CONTRIBUTIONS
Let us consider India further. Increases in per capita consumption of milk and
meat requiring more cereal grains will be comparatively higher in rural than in
urban areas. Therefore, not only must we produce more food for the growing
population, but satisfying demands for higher quality will necessitate increased
productivity in excess of projections for population growth.
Increased needs for food must be met using farming practices that are
sustainable. Of relevance are the new biotechnological tools for protecting crops
from insects, weeds, fungi, and viruses. Products already on the market or in
development include the following:
• Roundup Ready® corn provides new weed-control options for growers.
More than two million acres were planted in the U.S. in 1999; it will be
launched in a number of countries over the next two years.
• Corn protected from the European corn borer, is, essentially, a replacement
for insecticides, although it is also planted by farmers who would
otherwise not have sprayed because they could not properly time the
spraying or achieve effective insect control. We are seeing a mean yield
advantage of 13 bushels across the mid-west.
• A product in the pipeline for 2001 is corn protected from rootworm, a
major pest. We have obtained dramatic effects: well over 99 percent
control.
• Bollgard® cotton provides significant control of insects, saving farmers an
average of approximately four sprayings, depending on location. In the
mid-west, Roundup Ready® soybeans have received broad acceptance. In
1999, more than 50 percent of the U.S. soybean acreage was Roundup
Ready®.
• Roundup Ready® rice is showing promise. It will give farmers a new weed-
control option, and, in many places, will preclude the need to flood fields
to kill weeds, presenting the opportunity to conserve water.
• Roundup Ready® wheat is expected to be available in 2003, and our data
show great promise.
• Wheat with a protective gene remained healthy in laboratory tests after
infection with head scab, a major disease in North America and Europe.
These results promise reduced need for fungicide application, and
significant yield benefits in parts of the world in which spraying is not an
option.
A great deal of effort on the part of several companies is going into improving
oil quality, with potential human-health benefits, and there are opportunities
also to improve the seed-protein and oil values of corn to provide a better, more
balanced livestock feed.
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We have the ability to improve the starch content of potatoes. As french fries
are cooking, the water is replaced by oil; the higher the starch content, the less
oil in the finished product. So, for the fast food industry, fries with one-third
less oil are possible, which, combined with improved oil quality, would be
attractive to those concerned about fat and/or cholesterol. Although it would
never be a recommended food, the product is more nutritionally sound, clearly,
the permutations and capabilities now feasible present many new possibilities.
Lack of ß-carotene in the diet results in night blindness and, ultimately,
blindness for millions of people in developing countries. The technology exists
to increase the ß-carotene content of canola oil, which is used widely in India
and China. It is hard for industry to justify investing in a product without
the promise of a return on the investment. Through USAID, Monsanto found
the opportunity to donate this technology to provide significant health benefits
to people in many parts of the world. So I would argue that technologies
developed by Monsanto will actually make it easier for other companies to
introduce new products from minor crops to the market place.
PLANTS AS FACTORIES
We believe that many products that have pharmaceutical value, will, in the
future, be more economically produced in plants. Although farmers are excited
about this, I do not foresee vast areas planted to pharmaceutical crops; however,
the acres that are planted will be very valuable. While I believe the larger value
for the farmer will accrue from grains with improved protein and oil quality for
human consumption, the growing of crops with pharmaceutical applications
will be increasingly important. Compounds produced by fermentation today
will be produced in the future by moving the appropriate genes into plants.
NEW CHOICES
Biotechnology will provide new choices for farmers. They will “vote” every year
on whether to use the technology or not, which is the best competition of all.
As mentioned above, conventional use of chemicals is being pre-empted by the
choice of seed. The farmer will increasingly make decisions about pesticides
through their purchase of seeds.
The cotton grower who would have had to spray three times, and possibly up
to seventeen times in a single growing season, now can choose a product with
which he is virtually assured that spraying will be necessary only once or twice,
thus reducing personal exposure and environmental exposure.
We expect:
• greater production of value-added crops by contract,
• identity preservation of crops, if they have unique characteristics that have
value,
• global competition, and
• intensification of farming and the farm-supply industries.
KEYS TO SUCCESS
Success requires the right product in the right quantities at the right price.
Most of the food products of biotechnology are substitutes for others that meet
current demand. Ability to produce does not guarantee a market. Economical
pricing is essential, and high quality and efficient production are important.
By sharing value with people in the system, their participation is encouraged.
Monsanto has entered a joint venture with Cargill. Monsanto brings the
technology and Cargill brings knowledge of end-uses and how to extend the
system all the way to the consumer. Cargill also has the financial resources to
help fund this expensive research, which takes six or seven years from project
inception to the marketplace. Thus, by combining efforts and sharing costs, the
risks involved in developing new products are shared. However, even when two
such large entities combine, other players must be included in the collaboration
because no two companies possess the wherewithal to invent all the necessary
components or reach all the markets. Therefore, cross licensing of technology
and capability, and product sharing will be increasingly common.
Monsanto has invested in seed companies because seed is critical for
delivering the technology to the grower. For the same reason, DuPont has
invested in Pioneer.
GENOMICS
Having sequenced whole genomes, the next area of emphasis will be the linking
of specific genes to phenotypes. Information in this area is already exploding,
and the race is on to deliver new desirable traits to the market place.
We are excited because we currently use only about five percent of available
corn races, whereas this technology will allow us to choose genes from any corn
genotype, and other species of crops, and move specific desirable traits into
commercial corn. With genomics, we could have brought Roundup Ready®
soybeans to market two years earlier, and we will probably commercialize corn
with rootworm protection two years earlier than initially projected.
Furthermore, in the past, it was necessary to grow out and test every line of
soybean for a desired phenotype. We can now perform 10,000 tests per day to
check for resistance to cyst nematodes, for example, for just 10 percent of the
traditional cost. This efficient type of screening allows us to bring products
more quickly and more efficiently to the market place.
PATENT PROTECTION
In the U.S., newly commercialized products have patent protection, of which
growers are aware. In many developing countries there is no such safeguard. In
countries like India, the use of hybrids protects our technology — cotton for
example. In China we have a trademark license that the Chinese support, and,
in return, we provide seed of a quality higher than they have seen before.
Likewise, in Poland, we provide better seed-potato quality than previously
available.
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Chinese cotton growers buy seeds in 1-kg quantities. Over 500,000 of them
are planting our insect protected varieties on fields as small as a tenth of an
acre. They are excited about reducing their pesticide applications and
increasing the productivity of their family farms.
QUESTIONS FOR THE FUTURE
I conclude with some questions.
• Can we help consumers worldwide understand the benefits of biotechnology?
• Will the benefits from biotechnology be shared appropriately with farmers?
• Will the rewards stimulate continued investment?
• Can appropriate linkages or networks be formed?
• How fast will demand for high-quality food increase?
• Can biotechnology help us to make increased production a more sustainable
process?
